Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

Pfizer: Viagra revenue 2003-2019

Pfizer’s worldwide known erectile dysfunction product Viagra generated around 500 million U.S. dollars in revenue in 2019. Sales of this drug have decreased steadily over the past seven years, especially because patent protection expired outside the U.S. in 2012. In the United States, several drug manufacturers are currently allowed to market generic versions of Viagra (sildenafil), even if the patent is set to expire in 2020. This was the reason behind a further significant decline in sales in 2017-2018.

Drug manufacturer Pfizer

Drug manufacturer Pfizer is currently the world’s leading pharmaceutical company based on pure pharmaceutical sales of prescribed and over-the-counter drugs. The company is headquartered in Midtown Manhattan, New York City. Until 2013, the company also had a notable animal health product line. Today, the company is totally focused on human medicine, divided into two major segments - Innovative Health and Essential Health. Pfizer generates nearly half of its revenues inside the United States.

The rise of Viagra

Viagra was developed by scientists that were originally working on a drug for the treatment of hypertension and angina pectoris. During one of the trial phases the ‘adverse effect’ became obvious – while the targeted angina pectoris showed no improvement. Thus, it was approved for the market as an orally administered drug for erectile dysfunction in 1998. Pfizer’s Viagra has surely been one of the best-known and most discussed pharmaceutical products over the last few decades, entering even popular culture and becoming a synonym for potency. The drug, however, is also approved for treating pulmonary arterial hypertension.

Worldwide revenue of Pfizer's Viagra from 2003 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until October 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2020

Region

Worldwide

Survey time period

2003 to 2019

Supplementary notes

This statistic was assembled from several of Pfizer's annual and financial reports.
* Viagra lost exclusivity in the U.S. in December 2017. In 2018, revenues for Viagra in the U.S. and Canada, which were reported in IH through 2017, were reported in EH (which reported all other Viagra revenues excluding the U.S. and Canada through 2017). Therefore, in 2018, total Viagra worldwide revenues were reported in EH. Total Viagra revenues in 2017 and 2016 represented the aggregate of worldwide revenues from Viagra IH and Viagra EH.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pfizer"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.